Statistics about Society in United States
Statistics
- Bioaffinity Technologies liabilities 2021-2025
- Zymergen Inc. total assets 2020-2021
- Somalogic, Inc. total assets 2020-2022
- Optimus Healthcare Services liabilities 2021-2023
- Iqvia Holdings total assets 2021-2025
- Inotiv, Inc. liabilities 2021-2025
- Medpace Holdings total assets 2021-2025
- Incyte Corp liabilities 2021-2025
- Bioaffinity Technologies total assets 2021-2025
- Incyte Corp total assets 2021-2025
- Paychex total assets 2021-2025
- Omniab, Inc. total assets 2021-2025
- Omniab, Inc. liabilities 2021-2025
- Iqvia Holdings liabilities 2021-2025
- Science 37 Holdings, Inc. liabilities 2020-2022
- Medpace Holdings liabilities 2021-2025
- Maxcyte, Inc. liabilities 2021-2025
- U.S. Stem Cell, Inc. total assets 2018-2022
- Luna Innovations liabilities 2018-2022
- Academic R&D expenditure in the U.S. 2024, by funding source
- Federal obligations for R&D in the U.S. FY 1991-2025
- National Research Corp total equity 2021-2025
- Maxcyte, Inc. total equity 2021-2025
- Weed operating profit 2021-2025
- Iqvia Holdings total equity 2021-2025
- Foxo Technologies Inc. total equity 2021-2025
- Bioaffinity Technologies operating profit 2021-2025
- Optimus Healthcare Services total equity 2020-2023
- Ispecimen operating profit 2021-2025
- Maxcyte, Inc. net cash 2021-2025
- Maxcyte, Inc. revenue 2021-2025
- National Research Corp operating profit 2021-2025
- Ispecimen total equity 2021-2025
- Bioaffinity Technologies net cash 2021-2025
- Weed total equity 2021-2025
- Weed net cash 2021-2025
- Omniab, Inc. total equity 2021-2025
- Foxo Technologies Inc. operating profit 2021-2025
- Forrester Research net income 2021-2025
- Foxo Technologies Inc. revenue 2021-2025
- Ispecimen net cash 2021-2025
- Bioaffinity Technologies total equity 2021-2025
- Forrester Research total equity 2021-2025
- Maxcyte, Inc. gross profit 2021-2025
- Forrester Research revenue 2021-2025
- National Research Corp net income 2021-2025
- Foxo Technologies Inc. net cash 2021-2025
- Omniab, Inc. operating profit 2021-2025
- National Research Corp revenue 2021-2025
- National Research Corp net cash 2021-2025
- Omniab, Inc. net cash 2021-2025
- Forrester Research net cash 2021-2025
- Ispecimen revenue 2021-2025
- Omniab, Inc. revenue 2021-2025
- Maxcyte, Inc. net income 2021-2025
- Maxcyte, Inc. operating profit 2021-2025
- Bioaffinity Technologies revenue 2022-2025
- Forrester Research operating profit 2021-2025
- R&D spending as share of GDP in the U.S. 2024, by U.S. state
- R&D spending in the U.S. 1990-2024, by type of activity
- Real R&D spending in the U.S. 1990-2024
- R&D spending in the U.S. 1990-2024
- R&D spending in the U.S. 1990-2024, by source
- R&D spending in the U.S. 2024, by state
- Number of STEM degrees conferred by U.S. institutions 2008-2023, by gender
- Distribution of R&D spending companies by region and industry 2024
- ICT research and development expenditure in worldwide 2024, by country
- Medpace Holdings total equity 2021-2025
- Medpace Holdings net cash 2021-2025
- Medpace Holdings operating profit 2021-2025
- Medpace Holdings revenue 2021-2025
- Iqvia Holdings net cash 2021-2025
- Iqvia Holdings net income 2021-2025
- Iqvia Holdings operating profit 2021-2025
- Incyte Corp total equity 2021-2025
- Incyte Corp operating profit 2021-2025
- Incyte Corp net cash 2021-2025
- Incyte Corp revenue 2021-2025
- Incyte Corp net income 2021-2025
- Number of patents in force in the U.S. 2004-2024
- Patent publications from the U.S. 2024, by fields of technology
- Annual number of patent approvals from the U.S. 1980-2023
- Paychex total equity 2021-2025
- Paychex net cash 2020-2024
- Paychex revenue 2020-2024
- Paychex operating profit 2020-2024
- Paychex net income 2021-2024
- Inotiv, Inc. total equity 2021-2025
- Inotiv, Inc. net cash 2021-2025
- Inotiv, Inc. operating profit 2021-2025
- Inotiv, Inc. net income 2021-2025
- Inotiv, Inc. revenue 2021-2025
- Number of STEM degrees conferred by U.S. institutions 2008-2023, by degree level
- Number of STEM degrees conferred by U.S. institutions 2008-2023, by race/ethnicity
- Weed net income 2022 to 2024
- Federal funds for research at U.S. universities 2022, by department
- Zymergen Inc. total equity 2018-2021
- Zymergen Inc. net cash 2019-2021
- Zymergen Inc. liabilities 2020-2021
- Zymergen Inc. operating profit 2019-2021